The image shows a nanoballoon before (left) and after (right) being hit by a red laser. The laser causes the balloon to pop open and release the anti-cancer drugs directly at a tumor. Credit: Jonathan Lovell
New drug delivery method targets cancer cells – not the entire body – and limits chemotherapy side effects
Chemotherapeutic drugs excel at fighting cancer, but they’re not so efficient at getting where they need to go.
They often interact with blood, bone marrow and other healthy bodily systems. This dilutes the drugs and causes unwanted side effects.
Now, researchers are developing a better delivery method by encapsulating the drugs in nanoballoons – which are tiny modified liposomes that, upon being struck by a red laser, pop open and deliver concentrated doses of medicine.
Described April 3 in the journal Nature Communications, the innovation could improve cancer treatment, reduce its side effects and boost research about the disease, which annually kills millions of people worldwide.
The paper, “Porphyrin-phospholipid (PoP) liposomes permeabilized by near-infrared light,” is available here:
http://bit.ly/1q0kXFf.
“Why PoP-liposomes, or nanoballoons, open in response to an otherwise harmless red laser is still a bit of a mystery to us, but we have definitely unearthed a new and unique phenomenon,” said corresponding author Jonathan Lovell, PhD, UB assistant professor of biomedical engineering. “Its potential for improving how we treat cancer is immense.”
Additional authors include students and a research technician at UB, as well as collaborators from the University at Albany; Roswell Park Cancer Institute in Buffalo; and the University of Waterloo and McMaster University, both in Ontario, Canada.
Roughly 1,000 times thinner than human hair, nanoballoons consist of porphyrin, an organic compound, and phospholipid, a fat similar to vegetable oil. Like conventional chemotherapy, they would be delivered to patients intravenously.
But because the nanoballoons encapsulate the anti-cancer drugs, they diminish the drugs’ interaction with healthy bodily systems.
In laboratory experiments performed with mice, Lovell hits the nanoballoon with a red laser at the target site in the body. The laser triggers the nanoballoons to pop open and release the drugs. As soon as the laser is turned off, the nanoballoons close, taking in proteins and molecules that might induce cancer growth. Doctors could then be able to retrieve the nanoballoons by drawing blood or taking a biopsy.
Thus, the nanotechnology could provide a “chemical snapshot” of the tumor’s environment, which otherwise is very difficult to assess.
“Think of it this way,” Lovell said. “The nanoballoon is a submarine. The drug is the cargo. We use a laser to open the submarine door which releases the drug. We close the door by turning the laser off. We then retrieve the submarine as it circulates through the bloodstream.”
Lovell will continue fundamental studies to better understand why the treatment works so well in destroying tumors in mice, and to optimize the process. Human trials could start within five years, he said.
The Latest on: Drug delivery method
via Google News
The Latest on: Drug delivery method
- Microneedle Drug Delivery Systems Market Trend Shows a Rapid Growth Competitive Analysis Future Prospects and Forecast 2030on August 4, 2022 at 10:15 am
Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global ...
- New Nanorobots Have Immune Cell Biocompatibilityon August 4, 2022 at 6:53 am
Researchers have fabricated nanorobots using electron beam lithography, which is biocompatible with immune cells.
- Democrats' backdoor crackdown on pharma "gaming"on August 3, 2022 at 2:30 am
But the Democrats' proposal would allow Medicare to negotiate much lower prices for those drugs after a set period of time, slashing drugmakers' revenues years before competition enters the market.
- Prescription Delivery Services Market is set to experience a significant growth of 17.8% CAGR from 2022 to 2030on July 29, 2022 at 1:47 am
Timely drug delivery is the cornerstone of an effective healthcare infrastructure. Rising prevalence of chronic and infectious ailments have accelerated production of prescription drugs, prompting ...
- $1.7 Billion Worldwide Pharmaceutical Drug Delivery Industry to 2027 - Featuring GSK, Johnson & Johnson, Novartis and Pfizer Among Otherson July 29, 2022 at 1:33 am
Moreover, a significant increase in the number of death rates among the older population and individuals who have cancer is catalyzing the demand for pharmaceutical drug delivery systems. These ...
- Injectable Drug Delivery Market Type, Regional Outlook, Future Scope, and Leading Players, Trends, Demand Growth Revenue Analysis Report to 2028on July 27, 2022 at 10:16 pm
The global injectable drug delivery market is anticipated to rise at a CAGR of 12.9% to reach USD 1,251.28 billion by ...
- Becoming an Expert: Studying how long-acting drug delivery formulations interact with the human immune systemon July 25, 2022 at 11:57 pm
Danielle Brain is a fourth year PhD student and Research Associate in the Immunocompatibility Group, associated with the Centre of Excellence for Long-acting Therapeutics (CELT). Her PhD is funded by ...
- Global Pulmonary Drug Delivery Devices/Systems Market Provides an In-Depth Insight of Trends and Landscape Outlook (2022-2028)on July 25, 2022 at 11:05 pm
The report has referenced down-to-earth ideas of the global Pulmonary Drug Delivery Devices/Systems market in a straightforward and unassuming way in this report. It elaborates on the market scope and ...
- Global Pharmaceutical Drug Delivery Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecastson July 25, 2022 at 12:15 pm
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
- Scientists identify ‘bottleneck’ in drug delivery pathways in stem cellson July 19, 2022 at 5:00 pm
Researchers show that in certain types of cells, nanoparticles become ‘trapped’ within bubble-like vesicles and so are prevented from reaching their intended target during drug delivery ...
via Bing News